Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)

Oxytocin: Evidence Summary

Name: Oxytocin Evidence Summary — Clinical Trial Data
Published: 2026-03-12

Evidence summary for Oxytocin across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.

Back to Oxytocin overview

Indication	Evidence Tier	Trial Count	Summary
Labor induction and augmentation	Tier A	100	Standard of care for decades; definitive RCT evidence
Postpartum hemorrhage prevention	Tier A	50	Cochrane review confirms 30% blood loss reduction
Autism (social deficits)	Tier C	10	Mixed results — single-dose benefit vs no chronic dosing effect
PTSD and social anxiety	Tier D	5	Limited observational and small RCT data; ongoing trials